Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Aging|December 9, 2019
Cytological and genetic consequences for the progeny of a mitotic catastrophe provoked by Topoisomerase II deficiencyCristina Ramos-Pérez, Margaret Dominska, Laura Anaissi-Afonso, et al.
Auris, Nasus, Larynx|May 6, 2016
Complications after cochlear implantation in adult patients. 10-Year retrospective analysis of a tertiary academic centreCarlos Miguel Chiesa Estomba, Teresa Rivera Schmitz, Frank Alberto Betances Reinoso, et al.
Acta Otorrinolaringologica Espanola|December 17, 2008
[Alterations of balance in patients under 16 years of age distributed by age groups]Rubén Duilio Manrique Lipa, Andrés Soto Varela, Sofía Santos Pérez, et al.
Aging Cell|October 13, 2020
Thyroid hormones in diabetes, cancer, and agingBenoit R Gauthier, Alejandro Sola-García, María Ángeles Cáliz-Molina, et al.
Bioorganic & Medicinal Chemistry|February 25, 2017
5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluationPatricia Quintana-Espinoza, Pedro Martín-Acosta, Ángel Amesty, et al.
Biochemical Pharmacology|September 22, 2014
Yeast cytotoxic sensitivity to the antitumour agent β-lapachone depends mainly on oxidative stress and is largely independent of microtubule- or topoisomerase-mediated DNA damageCristina Ramos-Pérez, Isabel Lorenzo-Castrillejo, Oliver Quevedo, et al.
Plos One|September 3, 2010
Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3Yong-Hui Jiang, Yanzhen Pan, Li Zhu, et al.
Genes & Cancer|March 7, 2012
Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master RegulatorPetra Isabel Lorenzo, Elen Margrethe Brendeford, Siv Gilfillan, et al.
Genesis (New York, N.Y. : 2000)|March 25, 2024
An oocyte-specific Cas9-expressing mouse for germline CRISPR/Cas9-mediated genome editingDenise G Lanza, Jianqiang Mao, Isabel Lorenzo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 2, 2026
Geographic equity in oncology clinical trials in Spain: fragmentation, indicators, and evidenceAntonio David Lázaro Sánchez, Javier David Benítez Fuentes, María Teresa García García, et al.
Pageof 6